SEC Form D · Amendment · filed March 13, 2017
Arix Bioscience plc
Industry
Other Health Care
Location
LONDON, United Kingdom
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
James Rawlingson · LONDON, United KingdomExec · DirectorChristopher Evans · LONDON, United KingdomExec · DirectorDavid U'Prichard · LONDON, United KingdomDirectorTrevor Jones · LONDON, United KingdomDirectorFranz Humer · LONDON, United KingdomDirectorJohn Mutton Of Furness · LONDON, United KingdomDirectorJoseph Anderson · LONDON, United KingdomExec · DirectorJonathan Peacock · LONDON, United KingdomExec · DirectorJohn Banham · LONDON, United KingdomDirectorHernan M. Zaballa · Vancouver, British Columbia, CanadaExec · DirectorWillem Fuchter · Vancouver, British Columbia, CanadaDirectorDavid E. Doherty · Vancouver, British Columbia, CanadaDirectorEduardo E. Perlicz · Vancouver, British Columbia, CanadaDirectorCarlos E. Ponte · Vancouver, British Columbia, CanadaExec · DirectorPatrick E. Williams · La Veta, COExec · DirectorJohn E. Decooman · Vancouver, British Columbia, CanadaDirectorZula E. Kropivnitski · Vancouver, British Columbia, CanadaDirectorCassandra E. Gee · Vancouver, British Columbia, CanadaExec · DirectorGlenn E. Martin · Tucson, AZExec · DirectorNicole M. Breen · Tucson, AZExec · DirectorYosef Katz · Cedarhurst, NYExec · DirectorMoshe Schreiber · Cedarhurst, NYDirectorAnthony Young · Los Angeles, CADirectorRyan Krafft · Sherborn, MADirectorLindsey Krystofiak · SAN FRANCISCO, CADirectorThomas E. Willingham · Richmond, VADirectorAslam Merchant · ATLANTA, GAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗